Drug profile

The FDA adverse-event record for Clindamycin Hydrochloride Liquid 25 Mg

53 adverse-event reports submitted to the FDA Center for Veterinary Medicine reference Clindamycin Hydrochloride Liquid 25 Mg. See the species affected, top reactions, and outcomes below.

53
adverse-event reports
7.5%
death-coded share
Cat
most-reported species
10
Vomiting - top reaction
Verify with FDA CVM →
Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
53
Total Reports
4
Deaths Reported
7.5%
Death Rate

Active Ingredients

Clindamycin Hydrochloride Liquid 25 Mg

Administration Routes

OralUnknownOphthalmic

Species Affected

Cat 23
Unknown 15
Dog 13
Human 2

Most Affected Breeds

Unknown 17
Domestic Shorthair 10
Cat (unknown) 4
Domestic Mediumhair 3
Terrier - Yorkshire 3
Domestic Longhair 2
Dachshund (unspecified) 2
Maltese 2
Chihuahua 2
Persian 1

Most Reported Reactions

Vomiting 10
Uncoded sign 10
Diarrhoea 10
Lethargy (see also Central nervous system depression in 'Neurological') 5
Not eating 4
Behavioural disorder NOS 3
Vials, Abnormal 3
Vials, Leaking 3
Anorexia 3
Underfilling, Vials 2
Odor, Abnormal 2
Seizure NOS 2

Outcome Breakdown

Recovered/Normal
20 (52.6%)
Outcome Unknown
12 (31.6%)
Died
2 (5.3%)
Euthanized
2 (5.3%)
Ongoing
1 (2.6%)
Recovered with Sequela
1 (2.6%)

Clindamycin Hydrochloride Liquid 25 Mg Adverse Event Insights

53 reports name Clindamycin Hydrochloride Liquid 25 Mg; 4 recorded a death outcome (7.5% of reported events, not a population-level mortality rate). Active ingredient: Clindamycin Hydrochloride Liquid 25 Mg. Administration routes: Oral, Unknown, Ophthalmic.

By species: Cat (23 reports), Unknown (15 reports), Dog (13 reports). By breed: Unknown (17), Domestic Shorthair (10), Cat (unknown) (4).

Leading clinical signs: Vomiting (10), Uncoded sign (10), Diarrhoea (10), Lethargy (see also Central nervous system depression in 'Neurological') (5). Outcome, 38 coded reports: Recovered/Normal leads at 52.6%.

Read these counts as reporting volume, not risk: per our methodology, a widely-prescribed drug will rack up more raw FDA reports in a given year than a rarely-used one at an identical true rate, so we recommend comparing within similar-exposure products rather than across the full 2025 catalog.

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

Every figure on PlainBreed is rendered directly from FDA openFDA adverse event data, no number is typed in by an editor. This page draws directly on FDA openFDA data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.